Lannett Announces Positive Results of Facilities Inspection in Philadelphia

Lannett Company, Inc. LCI today said that the U.S. Food and Drug Administration (FDA) recently completed an inspection of the company's manufacturing facility in Philadelphia, Pennsylvania and Cody, Wyoming. The inspections concluded with “minor” observations, seven at the company's facilities in Philadelphia and five at Lannett's wholly owned subsidiary, Cody Laboratories (Cody), a manufacturer/supplier of pain management pharmaceutical products.